PatientsVille.com Logo

PatientsVille

Sti571/cgp57148b Side Effects

Common Sti571/cgp57148b Side Effects



➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Sti571/cgp57148b Side Effects Reported to FDA

The following Sti571/cgp57148b reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Sti571/cgp57148b on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

This is a report of a female patient (weight: NA) from GERMANY, suffering from the following symptoms/conditions: NA, who was treated with Sti571/cgp57148b (dosage: 400 Mg, Qd, start time: Mar 30, 2011), combined with:
  • Ramipril
  • Marcumar
and developed a serious reaction and side effect(s). The consumer presented with:
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Sti571/cgp57148b treatment in female patients, resulting in death side effect.

    Lymphadenopathy, Pancreatic Disorder, Abdominal Pain, Metastases To Liver, Hepatic Cyst, Tumour Haemorrhage
    This report suggests a potential Sti571/cgp57148b Lymphadenopathy, Pancreatic Disorder, Abdominal Pain, Metastases To Liver, Hepatic Cyst, Tumour Haemorrhage side effect(s) that can have serious consequences. A female patient (weight: NA) from THAILAND was diagnosed with the following symptoms/conditions: gastrointestinal stromal tumour and used Sti571/cgp57148b (dosage: 800 Mg, Daily) starting Jul 12, 2010. Soon after starting Sti571/cgp57148b the patient began experiencing various side effects, including:
    • Lymphadenopathy
    • Pancreatic Disorder
    • Abdominal Pain
    • Metastases To Liver
    • Hepatic Cyst
    • Tumour Haemorrhage
    Drugs used concurrently: NA.The patient was hospitalized. Although Sti571/cgp57148b demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as lymphadenopathy, may still occur.

    Febrile Bone Marrow Aplasia
    This Febrile Bone Marrow Aplasia problem was reported by a physician from FRANCE. A male patient (weight: NA) was diagnosed with the following symptoms/conditions: acute lymphocytic leukaemia. On Mar 01, 2011 this consumer started treatment with Sti571/cgp57148b (dosage: 400 Mg, Bid). The following drugs were being taken at the same time:
    • Stilnox
    • Zelitrex
    • Tavanic
    • Cytarabine (5650 Mg, Unk)
    • Methotrexate (1900 Mg, Unk)
    • Duphalac
    • Mopral
    • Efferalgan
    When commencing Sti571/cgp57148b, the patient experienced the following unwanted symptoms/side effects:
    • Febrile Bone Marrow Aplasia
    The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as febrile bone marrow aplasia, may become evident only after a product is in use by the general population.

    Pyrexia, Escherichia Infection, Septic Shock, Neoplasm Malignant
    This is a report of a female patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: acute lymphocytic leukaemia and was treated with Sti571/cgp57148b (dosage: Unk) starting Aug 10, 2009. Concurrently used drugs:
    • Cortancyl
    • Lexomil
    • Zelitrex
    • Esomeprazole
    • Stilnox
    Soon after that, the consumer experienced the following side effects:
    • Pyrexia
    • Escherichia Infection
    • Septic Shock
    • Neoplasm Malignant
    This opens a possibility that Sti571/cgp57148b treatment could cause the above reactions, including pyrexia, and some female subjects may be more susceptible.


    Subdural Haematoma, Gingival Bleeding, Altered State Of Consciousness, Cardiac Arrest
    A male patient (weight: NA) from TUNISIA with the following symptoms/conditions: gastrointestinal stromal tumour started Sti571/cgp57148b treatment (dosage: 400 Mg, Per Day) on Jun 26, 2010. Soon after starting Sti571/cgp57148b treatment, the subject experienced various side effects, including:
    • Subdural Haematoma
    • Gingival Bleeding
    • Altered State Of Consciousness
    • Cardiac Arrest
    Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Sti571/cgp57148b.

    Malignant Urinary Tract Neoplasm, Neoplasm Malignant
    A male patient from CHINA (weight: NA) experienced symptoms, such as: NA and was treated with Sti571/cgp57148b(dosage: 400 Mg, Daily). The treatment was initiated on Jan 11, 2008. After that a consumer reported the following side effect(s):
    • Malignant Urinary Tract Neoplasm
    • Neoplasm Malignant
    Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Sti571/cgp57148b efficacy: NA.The patient was hospitalized.

    Neutropenia, Vulval Abscess
    In this report, Sti571/cgp57148b was administered for the following condition: chronic myeloid leukaemia.A female consumer from AUSTRALIA (weight: NA) started Sti571/cgp57148b treatment (dosage: 600 Mg, Daily) on Nov 16, 2010.Sometime after starting the treatment, the patient complained of the following side effect(s):
    • Neutropenia
    • Vulval Abscess
    A possible interaction with other drugs could have contributed to this reaction:
    • Perindopril
    • Amlodipine Besylate
    • Hydrochlorothiazide
    • Enoxaparin
    • Rosuvastatin
    • Thyroxine
    The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Sti571/cgp57148b treatment could be related to the listed above side effect(s).

    Device Related Infection, Catheter Site Pain, Catheter Site Erythema
    This is a report of the following Sti571/cgp57148b side effect(s):
    • Device Related Infection
    • Catheter Site Pain
    • Catheter Site Erythema
    A 60-year-old female patient from UNITED STATES (weight: NA) presented with the following condition: pulmonary arterial hypertension and received a treatment with Sti571/cgp57148b (dosage: Unk) starting: May 05, 2010.The following concurrently used drugs could have generated interactions:
    • Remodulin
    The patient was hospitalized.This report suggests that a Sti571/cgp57148b treatment could be associated with the listed above side effect(s).

    Meningitis Herpes, Pancytopenia
    This Sti571/cgp57148b report was submitted by a 24-year-old female consumer from JAPAN (weight: NA). The patient was diagnosed with: NA and Sti571/cgp57148b was administered (dosage: 600 Mg, Daily) starting: Jun 07, 2009. The consumer developed a set of symptoms:
    • Meningitis Herpes
    • Pancytopenia
    Other drugs used simultaneously:
    • Predonine (90 Mg, Unk)
    • Predonine (20 Mg, Unk)
    • Baktar (1 Df, Unk)
    • Baktar (1 Df, Unk)
    • Lasix (40 Mg, Unk)
    • Primperan Tab (20 Mg, Unk)
    • Primperan Tab (10 Mg, Unk)
    • Saxizon (100 Mg, Unk)
    The patient was hospitalized.Those unexpected symptoms could be linked to a Sti571/cgp57148b treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

    Cerebral Disorder, Escherichia Bacteraemia, Pseudomembranous Colitis, Confusional State, Cardiac Arrest, Convulsion, Hyponatraemia
    This is a report of a possible correlation between Sti571/cgp57148b use and the following symptoms/side effect(s):
    • Cerebral Disorder
    • Escherichia Bacteraemia
    • Pseudomembranous Colitis
    • Confusional State
    • Cardiac Arrest
    • Convulsion
    • Hyponatraemia
    which could contribute to an assessment of Sti571/cgp57148b risk profile.A female consumer from SPAIN (weight: NA) was suffering from pulmonary arterial hypertension and was treated with Sti571/cgp57148b (dosage: Unk) starting Nov 03, 2010.Other concurrent medications:
    • Iloprost
    • Sintrom
    • Furosemide
    • Oxygen
    • Sildenafil
    • Spironolactone
    The patient was hospitalized.

    Bone Pain, Epstein-barr Virus Infection, Nausea, Blood Bilirubin Increased, Somnolence, Osteoporosis, Erythema, Skin Hyperpigmentation, Mucosal Inflammation
    A male patient from FRANCE (weight: NA) presented with the following symptoms: acute lymphocytic leukaemia and after a treatment with Sti571/cgp57148b (dosage: Unk) experienced the following side effect(s):
    • Bone Pain
    • Epstein-barr Virus Infection
    • Nausea
    • Blood Bilirubin Increased
    • Somnolence
    • Osteoporosis
    • Erythema
    • Skin Hyperpigmentation
    • Mucosal Inflammation
    The treatment was started on Oct 15, 2007. Sti571/cgp57148b was used in combination with the following drugs:
    • Morphine
    • Corticosteroids
    This report could alert potential Sti571/cgp57148b consumers.

    Urinary Tract Infection Enterococcal, Respiratory Distress, Ocular Hyperaemia, Eye Pain, Feeding Disorder, Diarrhoea, Aplasia, Iridocyclitis, Nausea
    In this report, a female patient from FRANCE (weight: NA) was affected by a possible Sti571/cgp57148b side effect.The patient was diagnosed with acute lymphocytic leukaemia. After a treatment with Sti571/cgp57148b (dosage: Unk, start date: NS), the patient experienced the following side effect(s):
    • Urinary Tract Infection Enterococcal
    • Respiratory Distress
    • Ocular Hyperaemia
    • Eye Pain
    • Feeding Disorder
    • Diarrhoea
    • Aplasia
    • Iridocyclitis
    • Nausea
    The following simultaneously used drugs could have led to this reaction: NA.The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Sti571/cgp57148b treatment.

    Concomitant Disease Progression, Back Pain, Intervertebral Disc Protrusion
    This is a report of a female patient from FRANCE (weight: NA), who used Sti571/cgp57148b (dosage: 400 Mg, Qd) for a treatment of chronic myeloid leukaemia. After starting a treatment on Feb 13, 2008, the patient experienced the following side effect(s):
    • Concomitant Disease Progression
    • Back Pain
    • Intervertebral Disc Protrusion
    The following drugs could possibly have interacted with the Sti571/cgp57148b treatment NA.The patient was hospitalized.Taken together, these observations suggest that a Sti571/cgp57148b treatment could be related to side effect(s), such as Concomitant Disease Progression, Back Pain, Intervertebral Disc Protrusion.

    Amaurosis Fugax, Cerebral Infarction
    This amaurosis fugax side effect was reported by a physician from FRANCE. A female patient (weight:NA) experienced the following symptoms/conditions: chronic myeloid leukaemia. The patient was prescribed Sti571/cgp57148b (dosage: 400 Mg, Bid), which was started on Apr 23, 2009. Concurrently used drugs:
    • Kardegic
    • Tramadol Hcl (Unk)
    • Hexaquine
    When starting to take Sti571/cgp57148b the consumer reported the following symptoms:
    • Amaurosis Fugax
    • Cerebral Infarction
    The patient was hospitalized. These side effects may potentially be related to Sti571/cgp57148b.

    Haemorrhage Intracranial
    This is a Sti571/cgp57148b side effect report of a female patient (weight:NA) from FRANCE, suffering from the following symptoms/conditions: acute lymphocytic leukaemia, who was treated with Sti571/cgp57148b (dosage:400 Mg, Bid, start time: Jan 27, 2011), combined with: NA., and developed a serious reaction and a haemorrhage intracranial side effect. The patient presented with:
    • Haemorrhage Intracranial
    which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Sti571/cgp57148b treatment in female patients suffering from acute lymphocytic leukaemia, resulting in haemorrhage intracranial.

    Confusional State, Hyponatraemia
    This report suggests a potential Sti571/cgp57148b confusional state side effect(s) that can have serious consequences. A female patient from SPAIN (weight:NA) was diagnosed with the following health condition(s): pulmonary arterial hypertension and used Sti571/cgp57148b (dosage: Unk) starting Nov 03, 2010. Soon after starting Sti571/cgp57148b the patient began experiencing various side effects, including:
    • Confusional State
    • Hyponatraemia
    Drugs used concurrently:NA. The patient was hospitalized. Although Sti571/cgp57148b demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as confusional state, may still occur.

    Pneumonia, Mental Status Changes, Disorientation, Somnolence, Endotracheal Intubation, Febrile Neutropenia, Delirium, Pneumonia Fungal
    This pneumonia problem was reported by a physician from UNITED STATES. A female patient (weight: NA) was diagnosed with the following medical condition(s): acute myeloid leukaemia.On Jan 19, 2011 a consumer started treatment with Sti571/cgp57148b (dosage: 800 Mg, Daily). The following drugs/medications were being taken at the same time:
    • Neupogen
    • Ativan
    • Cytarabine
    • Benadryl
    When commencing Sti571/cgp57148b, the patient experienced the following unwanted symptoms /side effects:
    • Pneumonia
    • Mental Status Changes
    • Disorientation
    • Somnolence
    • Endotracheal Intubation
    • Febrile Neutropenia
    • Delirium
    • Pneumonia Fungal
    The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as pneumonia, may become evident only after a product is in use by the general population.

    Nausea, Febrile Bone Marrow Aplasia, Diarrhoea, Abdominal Pain
    This is a Sti571/cgp57148b side effect report of a male patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: acute lymphocytic leukaemia and was treated with Sti571/cgp57148b (dosage: 400 Mg, Bid) starting Feb 14, 2008. Concurrently used drugs:
    • Methotrexate
    • Dexamethasone
    • Cytarabine
    Soon after that, the consumer experienced the following of symptoms:
    • Nausea
    • Febrile Bone Marrow Aplasia
    • Diarrhoea
    • Abdominal Pain
    The patient was hospitalized. This opens a possibility that Sti571/cgp57148b could cause nausea and that some male patients may be more susceptible.

    Venous Thrombosis, Neutropenia, Pain In Extremity, Diarrhoea, Corynebacterium Infection, Pyrexia, Leukopenia
    A female patient (weight: NA) from UNITED STATES with the following symptoms: pulmonary arterial hypertension started Sti571/cgp57148b treatment (dosage: 400 Mg, Qd) on Dec 02, 2010. Soon after starting Sti571/cgp57148b treatment, the consumer experienced several side effects, including:
    • Venous Thrombosis
    • Neutropenia
    • Pain In Extremity
    • Diarrhoea
    • Corynebacterium Infection
    • Pyrexia
    • Leukopenia
    . Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Sti571/cgp57148b side effects, such as venous thrombosis.

    Hypovolaemic Shock, Leukocytosis, Hypovolaemia, Anuria, Dermatitis Exfoliative, Renal Failure, Myelocytosis, Lymphadenopathy
    This hypovolaemic shock side effect was reported by a physician from FRANCE. A female patient (weight:NA) experienced the following symptoms/conditions: acute lymphocytic leukaemia.The patient was prescribed Sti571/cgp57148b (dosage: 800 Mg, A Day), which was started on Nov 16, 2009. Concurrently used drugs:
    • Bactrim (Unk)
    • Zelitrex
    • Topalgic
    • Depo-medrol
    .When starting to take Sti571/cgp57148b the consumer reported symptoms, such as:
    • Hypovolaemic Shock
    • Leukocytosis
    • Hypovolaemia
    • Anuria
    • Dermatitis Exfoliative
    • Renal Failure
    • Myelocytosis
    • Lymphadenopathy
    These side effects may potentially be related to Sti571/cgp57148b.

    Escherichia Infection, Septic Shock, Pyrexia
    This is a report of a female patient (weight: NA) from FRANCE, suffering from the following symptoms/conditions: acute lymphocytic leukaemia, who was treated with Sti571/cgp57148b (dosage: Unk, start time: NS), combined with:
    • Cortancyl
    • Esomeprazole
    • Lexomil
    • Zelitrex
    • Stilnox
    and developed a serious reaction and side effect(s). The consumer presented with:
    • Escherichia Infection
    • Septic Shock
    • Pyrexia
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Sti571/cgp57148b treatment in female patients, resulting in escherichia infection side effect.

    Haemorrhage Intracranial
    This report suggests a potential Sti571/cgp57148b Haemorrhage Intracranial side effect(s) that can have serious consequences. A female patient (weight: NA) from FRANCE was diagnosed with the following symptoms/conditions: acute lymphocytic leukaemia and used Sti571/cgp57148b (dosage: 400 Mg, Bid) starting Jan 27, 2011. Soon after starting Sti571/cgp57148b the patient began experiencing various side effects, including:
    • Haemorrhage Intracranial
    Drugs used concurrently: NA. Although Sti571/cgp57148b demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as haemorrhage intracranial, may still occur.

    Gastrointestinal Haemorrhage, Cardiac Failure, Performance Status Decreased, Disease Progression, Enterocutaneous Fistula
    This Gastrointestinal Haemorrhage, Cardiac Failure, Performance Status Decreased, Disease Progression, Enterocutaneous Fistula problem was reported by a physician from MEXICO. A male patient (weight: NA) was diagnosed with the following symptoms/conditions: gastrointestinal stromal tumour. On NS this consumer started treatment with Sti571/cgp57148b (dosage: 400 Mg, Bid). The following drugs were being taken at the same time:
    • Omeprazole
    When commencing Sti571/cgp57148b, the patient experienced the following unwanted symptoms/side effects:
    • Gastrointestinal Haemorrhage
    • Cardiac Failure
    • Performance Status Decreased
    • Disease Progression
    • Enterocutaneous Fistula
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as gastrointestinal haemorrhage, may become evident only after a product is in use by the general population.

    Liver Function Test Abnormal, Pulmonary Embolism, Aspergillosis, Cytolytic Hepatitis, Thrombophlebitis Superficial, Stent Placement
    This is a report of a female patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: NA and was treated with Sti571/cgp57148b (dosage: Unk) starting Aug 03, 2009. Concurrently used drugs:
    • Vfend
    • Doxorubicin (92 Mg, Qd)
    Soon after that, the consumer experienced the following side effects:
    • Liver Function Test Abnormal
    • Pulmonary Embolism
    • Aspergillosis
    • Cytolytic Hepatitis
    • Thrombophlebitis Superficial
    • Stent Placement
    This opens a possibility that Sti571/cgp57148b treatment could cause the above reactions, including liver function test abnormal, and some female subjects may be more susceptible.

    Nausea, Reflux Gastritis, Weight Decreased, Vomiting, Decreased Appetite, Helicobacter Gastritis, Abdominal Pain, Malaise, Headache
    A male patient (weight: NA) from AUSTRALIA with the following symptoms/conditions: chronic myeloid leukaemia,hypertension,agranulocytosis started Sti571/cgp57148b treatment (dosage: 800 Mg, Qd) on Apr 18, 2006. Soon after starting Sti571/cgp57148b treatment, the subject experienced various side effects, including:
    • Nausea
    • Reflux Gastritis
    • Weight Decreased
    • Vomiting
    • Decreased Appetite
    • Helicobacter Gastritis
    • Abdominal Pain
    • Malaise
    • Headache
    Concurrently used drugs:
    • Atenolol
    • Aspirin
    • Valproate Bismuth
    The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Sti571/cgp57148b.

    1 of 17 



    Top 10 Sti571/cgp57148b Side Effects for Women

    Women Side EffectsReports
    Nausea 22
    Dehydration 21
    Abdominal Pain Upper 18
    Vomiting 15
    Gastritis 14
    Abdominal Pain 12
    Dyspnoea 12
    Pyrexia 12
    Anaemia 11
    Liver Function Test Abnormal 11

    Top 10 Sti571/cgp57148b Side Effects for Men

    Men Side EffectsReports
    Abdominal Pain 29
    Dyspnoea 28
    Nausea 26
    Diarrhoea 22
    Fatigue 22
    Anaemia 21
    Malignant Neoplasm Progression 20
    Headache 18
    Asthenia 17
    Dizziness 17

    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Sti571/cgp57148b Side Effects

    Did You Have a Sti571/cgp57148b Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Sti571/cgp57148b for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Sti571/cgp57148b Safety Alerts, Active Ingredients, Usage Information

    More About Sti571/cgp57148b

    Side Effects reported to FDA: 403

    Sti571/cgp57148b safety alerts: No

    Reported deaths: 47

    Reported hospitalizations: 158

    Latest Sti571/cgp57148b clinical trials

    Sti571/cgp57148b Reviews

    No reviews, be a first to report a side effect via side effect reporting form